The Best and Worst Dow Stocks
It also acts as a reference point for analysts and investors. However, not all stocks within this elite group of companies perform equally.
Merck & Co. Inc. (MRK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Antipodes Partners Jacob Mitchell | 1,967,970 | $176,659,161 | +7% | 5.53% |
| 2. | Impax Asset Management Ian Simm | 399,284 | $35,839,732 | -11% | 0.22% |
| 3. | RWC Asset Management Tord Stallvik (Ceo) | 249,253 | $22,372,949 | -5% | 1.15% |
| 4. | Bourgeon Capital John Zaro | 150,158 | $13,478,364 | +2% | 2.9% |
| 5. | Levin Easterly Partners John Murphy | 139,343 | $12,507,470 | -13% | 1.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $88.25 | 2,833 | Director | 2,933 | 2025-02-06 | Filing | |
| $88.50 | 15,000 | Director | 16,000 | 2025-02-05 | Filing | |
| $113.68 | 3 | Officer | 20,599 | 2023-04-26 | Filing | |
| $105.47 | 136 | Officer | 20,631 | 2023-03-20 | Filing | |
| $109.20 | 11 | Officer | 20,495 | 2023-02-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.76 | 4,262 | Officer | 7,778 | 2025-04-25 | Filing | |
| $84.09 | 8,500 | Officer | 30,705 | 2025-02-19 | Filing | |
| $85.34 | 6,000 | Officer | 24,123 | 2025-02-13 | Filing | |
| $88.76 | 2,361 | Officer | 7,085 | 2025-02-06 | Filing | |
| $125.50 | 38,291 | Officer | 50,908 | 2024-02-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 225,398,231 | $20,231,745,187 | 0.42% | |
| 2. | 23,130,857 | $2,076,225,813 | 0.41% | |
| 3. | 7,983,193 | $716,571,404 | 0.24% | |
| 4. | 7,285,677 | $653,962,368 | 0.46% | |
| 5. | 5,629,432 | $505,297,886 | 0.28% |
News See All
Merck & Co., Inc. (MRK): A Bull Case Theory
We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Investing Intel. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.
Billionaire Mario Gabelli's 10 Large-Cap Stock Picks with Huge Upside Potential
Mario Gabelli needs no introduction, having risen to become one of the most successful money managers on Wall Street, backed by a research-driven equity investment style.
10 Most Profitable Cheap Stocks to Buy Now
US stocks rose on Friday, May 2, as the S&P 500, Dow Jones Industrial Average, and the tech-heavy Nasdaq all posted impressive gains.
Jim Cramer's Surprised About US Travel As He Discusses These 18 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the growing amount of stock buybacks and how the buybacks during April-May were the third best historically of the year.
The Best and Worst Dow Stocks for the Next 12 Months
The Dow Jones Industrial Average (DJIA), or the Dow, is a price-weighted index that has long been seen as a barometer of the health of the U.S. economy.
Billionaire Cliff Asness' 10 Stock Picks with Huge Upside Potential
Cliff Asness, the founder, managing principal, and chief investment officer of AQR Capital Management, is a well-known figure in the world of finance.
11 Worst-Performing Blue Chip Stocks So Far in 2025
Blue chip stocks are under immense pressure amid the evolving trade tensions and tariff announcements around the globe.
Top 10 Buzzing Stocks You Should Watch Today
“These are hideous depressing days for the bulls. I'm not used to seeing a White House that doesn't seem to care that it's causing the decline.
Billionaire Ken Fisher's 10 Healthcare Stock Picks with Massive Upside Potential
The healthcare industry, an essential component of global well-being and economic resilience, is undergoing significant changes.
Billionaire Hedge Funds
